Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

被引：45

作者：

Bedaiwy, Mohamed A.

Casper, Robert F. ^{[1
]}

机构：

[1] Univ Toronto, Div Reprod Sci, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada

[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

来源：

FERTILITY AND STERILITY | 2006年 / 86卷 / 01期

关键词：

D O I：

10.1016/j.fertnstert.2005.12.030

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This pilot study examined the effect of a low-dose E and pulsed progestogen hormone therapy (HT) regimen for add-back during long-term GnRH-agonist therapy on bone mineral density (BMD) in five patients with stage IV endometriosis. Bone mineral density was stable after initiation of HT for the entire follow-up period (up to 10 years). One patient stopped her treatment on two occasions to conceive and was successful each time with delivery of a normal baby. No patient had return of pelvic pain after HT add-back.

引用

收藏

页码：220 / 222

页数：3

相关论文

共 14 条

[1] LONG-TERM GONADOTROPIN-RELEASING-HORMONE AGONIST THERAPY - THE EVOLVING ISSUE OF STEROIDAL ADD-BACK PARADIGMS [J].

ADASHI, EY .

HUMAN REPRODUCTION, 1994, 9 (07) :1380-1397

[2] GONADOTROPIN-RELEASING HORMONE AGONISTS AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY [J].

BARBIERI, RL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (02) :593-595

[3]

CASPER RF, 1991, CAN MED ASSOC J, V144, P153

[4] Estrogen with interrupted progestin HRT: a review of experimental and clinical studies [J].

Casper, RF .

MATURITAS, 2000, 34 (02) :97-108

[5] The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: A model for the effects of polycystic ovarian disease on the skeleton? [J].

Lundon, KM ;

Jayo, MJ ;

Register, TC ;

Dumitriu, M ;

Grynpas, MD .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (09) :778-789

[6] PREVALENCE AND GENESIS OF ENDOMETRIOSIS [J].

MAHMOOD, TA ;

TEMPLETON, A .

HUMAN REPRODUCTION, 1991, 6 (04) :544-549

[7] Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist [J].

Miller, JD ;

Shaw, RW ;

Casper, RFJ ;

Rock, JA ;

Thomas, EJ ;

Dmowski, WP ;

Surrey, E ;

Malinak, LR ;

Moghissi, K .

FERTILITY AND STERILITY, 1998, 70 (02) :293-296

[8] Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome [J].

Mitwally, MFM ;

Gotlieb, L ;

Casper, RF .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2002, 9 (04) :236-241

[9] Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog [J].

Paoletti, AM ;

Serra, GG ;

Cagnacci, A ;

Vacca, AMB ;

Guerriero, S ;

Solla, E ;

Melis, GB .

FERTILITY AND STERILITY, 1996, 65 (04) :707-710

[10] GnRH agonists and add-back therapy: is there a perfect combination? [J].

Pickersgill, A .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (05) :475-485